Stocktoria
Vanda Pharmaceuticals Inc. VNDA
Vanda Pharmaceuticals Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 8,138,252 | $46.0M | 13.77% |
| RENAISSANCE TECHNOLOGIES LLC | 3,759,559 | $26.0M | 6.36% |
| MILLENNIUM MANAGEMENT LLC | 1,881,001 | $13.0M | 3.18% |
| AQR CAPITAL MANAGEMENT LLC | 1,603,576 | $11.1M | 2.71% |
| TWO SIGMA INVESTMENTS, LP | 1,398,201 | $9.7M | 2.37% |
| CITADEL ADVISORS LLC | 825,254 | $5.7M | 1.4% |
| Point72 Asset Management, L.P. | 161,596 | $1.1M | 0.27% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.